67
Participants
Start Date
October 31, 2007
Primary Completion Date
July 31, 2009
Study Completion Date
December 31, 2009
Arsenic trioxide
Arsenic trioxide will be administered intravenously (iv) at a dose of 0.25 mg/kg.
Low-dose cytarabine alone
Cytarabine will be administered at a dose of 10 mg/m\^2 subcutaneously (sc) twice a day (bid).
St. Vincent's Comprehensive Cancer Center, New York
Weill Medical College of Cornell University, New York
Roswell Park Cancer Institute, Buffalo
Brody School of Medicine, Greenville
Medical University of South Carolina, Charleston
Indiana Oncology Hematology Consultants, Indianapolis
University of Illinois, Chicago
University of Oklahoma, Oklahoma City
UT Health Science Center, San Antonio
USC / Norris Cancer Hospital, Los Angeles
UCLA Medical Center, Los Angeles
Princess Margaret Hospital, Toronto
Lead Sponsor
Cephalon
INDUSTRY